These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 27621614)
1. Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients. Erdal M; Johannessen A; Eagan TM; Bakke P; Gulsvik A; Grønseth R Int J Chron Obstruct Pulmon Dis; 2016; 11():2099-108. PubMed ID: 27621614 [TBL] [Abstract][Full Text] [Related]
2. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort. Yohannes AM; Mülerová H; Lavoie K; Vestbo J; Rennard SI; Wouters E; Hanania NA J Am Med Dir Assoc; 2017 Nov; 18(11):955-959.e6. PubMed ID: 28733182 [TBL] [Abstract][Full Text] [Related]
3. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK. Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512 [TBL] [Abstract][Full Text] [Related]
4. COPD exacerbation frequency and its association with health care resource utilization and costs. Dhamane AD; Moretz C; Zhou Y; Burslem K; Saverno K; Jain G; Renda A; Kaila S Int J Chron Obstruct Pulmon Dis; 2015; 10():2609-18. PubMed ID: 26664109 [TBL] [Abstract][Full Text] [Related]
5. Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study. Johannesdottir SA; Christiansen CF; Johansen MB; Olsen M; Xu X; Parker JM; Molfino NA; Lash TL; Fryzek JP J Med Econ; 2013 Jul; 16(7):897-906. PubMed ID: 23621504 [TBL] [Abstract][Full Text] [Related]
6. Association between incidence of acute exacerbation and medication therapy in patients with COPD. Suh DC; Lau H; La HO; Choi IS; Geba GP Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283 [TBL] [Abstract][Full Text] [Related]
7. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence. Blais L; Forget A; Ramachandran S Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680 [TBL] [Abstract][Full Text] [Related]
8. A score to predict short-term risk of COPD exacerbations (SCOPEX). Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896 [TBL] [Abstract][Full Text] [Related]
9. The reasons for triple therapy in stable COPD patients in Japanese clinical practice. Miyazaki M; Nakamura H; Takahashi S; Chubachi S; Sasaki M; Haraguchi M; Terai H; Ishii M; Fukunaga K; Tasaka S; Soejima K; Asano K; Betsuyaku T; Int J Chron Obstruct Pulmon Dis; 2015; 10():1053-9. PubMed ID: 26082629 [TBL] [Abstract][Full Text] [Related]
10. Self-reported alcohol intake and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study. Wetherbee EE; Niewoehner DE; Sisson JH; Lindberg SM; Connett JE; Kunisaki KM Int J Chron Obstruct Pulmon Dis; 2015; 10():1363-70. PubMed ID: 26229455 [TBL] [Abstract][Full Text] [Related]
11. Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population. Moll K; Sun SX; Ellis JJ; Howe A; Amin A Int J Chron Obstruct Pulmon Dis; 2015; 10():565-76. PubMed ID: 25834417 [TBL] [Abstract][Full Text] [Related]
12. Long term effects of an integrated care intervention on hospital utilization in patients with severe COPD: a single centre controlled study. Titova E; Steinshamn S; Indredavik B; Henriksen AH Respir Res; 2015 Feb; 16(1):8. PubMed ID: 25645122 [TBL] [Abstract][Full Text] [Related]
13. [Comprehension and recognition of acute exacerbation among chronic obstructive pulmonary disease patients]. Jiang M; Ma JF Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Oct; 34(10):1030-4. PubMed ID: 24378002 [TBL] [Abstract][Full Text] [Related]
14. Predictors of exacerbations in chronic obstructive pulmonary disease--results from the Bergen COPD cohort study. Husebø GR; Bakke PS; Aanerud M; Hardie JA; Ueland T; Grønseth R; Persson LJ; Aukrust P; Eagan TM PLoS One; 2014; 9(10):e109721. PubMed ID: 25279458 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD. Wilson R; Anzueto A; Miravitlles M; Arvis P; Haverstock D; Trajanovic M; Sethi S Int J Chron Obstruct Pulmon Dis; 2015; 10():985-93. PubMed ID: 26082623 [TBL] [Abstract][Full Text] [Related]
16. Newly diagnosed gastroesophageal reflux disease increased the risk of acute exacerbation of chronic obstructive pulmonary disease during the first year following diagnosis--a nationwide population-based cohort study. Lin YH; Tsai CL; Chien LN; Chiou HY; Jeng C Int J Clin Pract; 2015 Mar; 69(3):350-7. PubMed ID: 25359162 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013. Raluy-Callado M; Lambrelli D; MacLachlan S; Khalid JM Int J Chron Obstruct Pulmon Dis; 2015; 10():925-37. PubMed ID: 25999708 [TBL] [Abstract][Full Text] [Related]